Schupp JC, Freitag-Wolf S, Bargagli E, et al. Phenotypes of organ involvement in sarcoidosis. Eur Respir J. 2018; https://doi.org/10.1183/13993003.00991-2017.

Article  Google Scholar 

Ungprasert P, Carmona EM, Utz JP, Ryu JH, Crowson CS, Matteson EL. Epidemiology of sarcoidosis 1946–2013: a population-based study. Mayo Clin Proc. 2016;91(2):183–8. https://doi.org/10.1016/j.mayocp.2015.10.024.

Article  Google Scholar 

Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, Müller-Quernheim J. Sarcoidosis. Nat Rev Dis Primers. 2019;5(1):45. https://doi.org/10.1038/s41572-019-0096-x.

Article  Google Scholar 

Drent M, Crouser ED, Grunewald J. Challenges of sarcoidosis and its management. N Engl J Med. 2021;385(11):1018–32. https://doi.org/10.1056/NEJMra2101555.

Article  Google Scholar 

Arkema EV, Cozier YC. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med. 2020;26(5):527–34. https://doi.org/10.1097/MCP.0000000000000715.

Article  Google Scholar 

Prasse A. The diagnosis, differential diagnosis, and treatment of sarcoidosis. Dtsch Arztebl Int. 2016;113(33):565–74. https://doi.org/10.3238/arztebl.2016.0565.

Article  PubMed Central  Google Scholar 

Baughman RP, Field S, Costabel U, et al. Sarcoidosis in america. Analysis based on health care use. Ann Am Thorac Soc. 2016;13(8):1244–52. https://doi.org/10.1513/AnnalsATS.201511-760OC.

Article  Google Scholar 

Crouser ED, Maier LA, Wilson KC, et al. Diagnosis and detection of sarcoidosis. An official American thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(8):e26–e51. https://doi.org/10.1164/rccm.202002-0251ST.

Article  PubMed Central  Google Scholar 

Pagán AJ, Ramakrishnan L. The formation and function of granulomas. Annu Rev Immunol. 2018;36:639–65. https://doi.org/10.1146/annurev-immunol-032712-100022.

Article  Google Scholar 

Meyer KC, Raghu G, Baughman RP, et al. An official American thoracic society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185(9):1004–14. https://doi.org/10.1164/rccm.201202-0320ST.

Article  Google Scholar 

Kraaijvanger R, Janssen Bonás M, Vorselaars ADM, Veltkamp M. Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects. Front Immunol. 2020;11:1443. https://doi.org/10.3389/fimmu.2020.01443.

Article  PubMed Central  Google Scholar 

Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet P‑Y, Müller-Quernheim J. Sarcoidosis. Lancet. 2014;383(9923):1155–67. https://doi.org/10.1016/S0140-6736(13)60680-7.

Article  Google Scholar 

Thillai M, Atkins CP, Crawshaw A, et al. BTS clinical statement on pulmonary sarcoidosis. Thorax. 2021;76(1):4–20. https://doi.org/10.1136/thoraxjnl-2019-214348.

Article  Google Scholar 

Baughman RP, Janovcik J, Ray M, Sweiss N, Lower EE. Calcium and vitamin D metabolism in sarcoidosis. Sarcoidosis. 2013;30(2):113–20.

Google Scholar 

Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years’ observation. Br Med J. 1961;2(5261):1165–72. https://doi.org/10.1136/bmj.2.5261.1165.

Article  PubMed Central  Google Scholar 

Bandyopadhyay D, Mirsaeidi MS. Sarcoidosis-associated pulmonary fibrosis: joining the dots. Eur Respir Rev. 2023; https://doi.org/10.1183/16000617.0085-2023.

Article  PubMed Central  Google Scholar 

Desai SR, Sivarasan N, Johannson KA, et al. High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study. Lancet Respir Med. 2023; https://doi.org/10.1016/S2213-2600(23)00267-9.

Article  Google Scholar 

Judson MA. The management of sarcoidosis in the 2020s by the primary care physician. Am J Med. 2023;136(6):534–44. https://doi.org/10.1016/j.amjmed.2023.02.014.

Article  Google Scholar 

Keijsers RGM, Grutters JC. In which patients with sarcoidosis is FDG PET/CT indicated? J Clin Med. 2020; https://doi.org/10.3390/jcm9030890.

Article  PubMed Central  Google Scholar 

Treglia G, Annunziata S, Sobic-Saranovic D, Bertagna F, Caldarella C, Giovanella L. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review. Acad Radiol. 2014;21(5):675–84. https://doi.org/10.1016/j.acra.2014.01.008.

Article  Google Scholar 

Blankstein R, Waller AH. Evaluation of known or suspected cardiac sarcoidosis. Circ Cardiovasc Imaging. 2016;9(3):e867. https://doi.org/10.1161/CIRCIMAGING.113.000867.

Article  Google Scholar 

Judson MA. Environmental risk factors for sarcoidosis. Front Immunol. 2020;11:1340. https://doi.org/10.3389/fimmu.2020.01340.

Article  PubMed Central  Google Scholar 

Rossides M, Grunewald J, Eklund A, et al. Familial aggregation and heritability of sarcoidosis: a Swedish nested case-control study. Eur Respir J. 2018; https://doi.org/10.1183/13993003.00385-2018.

Article  PubMed Central  Google Scholar 

Rybicki BA, Iannuzzi MC, Frederick MM, et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med. 2001;164(11):2085–91. https://doi.org/10.1164/ajrccm.164.11.2106001.

Article  Google Scholar 

Linke M, Pham HTT, Katholnig K, et al. Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression. Nat Immunol. 2017;18(3):293–302. https://doi.org/10.1038/ni.3655.

Article  PubMed Central  Google Scholar 

Pacheco Y, Lim CX, Weichhart T, Valeyre D, Bentaher A, Calender A. Sarcoidosis and the mTOR, Rac1, and autophagy triad. Trends Immunol. 2020;41(4):286–99. https://doi.org/10.1016/j.it.2020.01.007.

Article  Google Scholar 

Pizzini A, Bacher H, Aichner M, et al. High expression of mTOR signaling in granulomatous lesions is not predictive for the clinical course of sarcoidosis. Respir Med. 2021;177:106294. https://doi.org/10.1016/j.rmed.2020.106294.

Article  Google Scholar 

Bueno-Beti C, Lim CX, Protonotarios A, et al. An mTORC1-dependent mouse model for cardiac sarcoidosis. J Am Heart Assoc. 2023;12(19):e30478. https://doi.org/10.1161/JAHA.123.030478.

Article  PubMed Central  Google Scholar 

Baughman RP, Judson MA, Wells A. The indications for the treatment of sarcoidosis: Wells Law. Sarcoidosis. 2017;34(4):280–2. https://doi.org/10.36141/svdld.v34i4.6957.

Article  Google Scholar 

Hu X, Carmona EM, Yi ES, Pellikka PA, Ryu J. Causes of death in patients with chronic sarcoidosis. Sarcoidosis. 2016;33(3):275–80.

Google Scholar 

Moor CC, van Manen MJG, van Hagen PM, et al. Needs, perceptions and education in sarcoidosis: a live interactive survey of patients and partners. Lung. 2018;196(5):569–75. https://doi.org/10.1007/s00408-018-0144-4.

Article  PubMed Central  Google Scholar 

Baughman RP, Barriuso R, Beyer K, et al. Sarcoidosis: patient treatment priorities. ERJ Open Res. 2018; https://doi.org/10.1183/23120541.00141-2018.

Article  PubMed Central  Google Scholar 

Patel AS, Siegert RJ, Creamer D, et al. The development and validation of the King’s sarcoidosis questionnaire for the assessment of health status. Thorax. 2013;68(1):57–65. https://doi.org/10.1136/thoraxjnl-2012-201962.

Article  Google Scholar 

Drent M, Costabel U, Crouser ED, Grunewald J, Bonella F. Misconceptions regarding symptoms of sarcoidosis. Lancet Respir Med. 2021;9(8):816–8. https://doi.org/10.1016/S2213-2600(21)00311-8.

Article  Google Scholar 

Bosse-Henck A, Wirtz H, Hinz A. Organ manifestation and subjective sleep quality in sarcoidosis. Pneumologie. 2016;70(8):522–9. https://doi.org/10.1055/s-0042-100554.

Article  Google Scholar 

Hendriks C, Drent M, De Kleijn W, Elfferich M, Wijnen P, De Vries J. Everyday cognitive failure and depressive symptoms predict fatigue in sarcoidosis: a prospective follow-up study. Respir Med. 2018;138:S24–S30. https://doi.org/10.1016/j.rmed.2017.11.008.

Article  Google Scholar 

Moor CC, Kahlmann V, Culver DA, Wijsenbeek MS. Comprehensive care for patients with sarcoidosis. J Clin Med. 2020; https://doi.org/10.3390/jcm9020390.

Article  PubMed Central  Google Scholar 

Saketkoo LA, Russell A‑M, Jensen K, et al. Health-related quality of life (HRQoL) in sarcoidosis: diagnosis, management, and health outcomes. Diagnostics. 2021; https://doi.org/10.3390/diagnostics11061089.

Article